Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
United States of America
COVID-19
Pneumococcal disease
Adults
Clear all
Type of publications
NITAG documentation
(3)
Systematic reviews (SYSVAC)
(2)
Topics
Regions
Americas
(5)
Countries
United States of America
(5)
Algeria
(1)
Australia
(2)
Belgium
(1)
China
(12)
India
(1)
Japan
(1)
Nigeria
(2)
Saudi Arabia
(2)
United Kingdom
(4)
Diseases
COVID-19
(1)
Pneumococcal disease
(4)
Diphtheria
(1)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(2)
Human papillomavirus (HPV)
(20)
Influenza
(4)
Japanese encephalitis
(2)
Meningococcal disease
(2)
Mumps
(1)
Pertussis
(2)
Rabies
(1)
Tetanus
(1)
Publication date
2022
(2)
2019
(1)
2018
(1)
2017
(1)
Target population
Adults
(5)
Adolescents
(3)
Children
(3)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(4)
Risk group
(2)
Available to download in languages
English (EN)
(3)
5 results found
2022
∙
Dhanani, Lindsay Y. Franz, Berkeley
A Meta-Analysis of COVID-19 Vaccine Attitudes and Demographic Characteristics in the United States
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2019
∙
Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.
Cost-effectiveness of adult vaccinations: A systematic review
2018
∙
ACIP
October 2018 - meeting minutes
2017
∙
ACIP
October 2017 - meeting minutes
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register